Afya (NASDAQ:AFYA) Coverage Initiated at The Goldman Sachs Group

Analysts at The Goldman Sachs Group initiated coverage on shares of Afya (NASDAQ:AFYA) in a report issued on Tuesday, Marketbeat.com reports. The firm set a “sell” rating and a $16.00 price target on the stock. The Goldman Sachs Group’s target price points to a potential downside of 1.11% from the stock’s current price.

Separately, UBS Group assumed coverage on shares of Afya in a report on Friday, August 30th. They issued a “neutral” rating and a $19.50 price objective for the company.

Afya Trading Up 1.4 %

Shares of AFYA stock opened at $16.18 on Tuesday. The company has a 50 day moving average of $16.79 and a 200-day moving average of $17.10. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.51. Afya has a 12-month low of $15.28 and a 12-month high of $22.48. The firm has a market cap of $1.52 billion, a P/E ratio of 13.05, a PEG ratio of 0.34 and a beta of 0.89.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Public Employees Retirement System of Ohio bought a new position in Afya in the 3rd quarter valued at $34,000. State Street Corp boosted its holdings in Afya by 118.2% in the 3rd quarter. State Street Corp now owns 73,098 shares of the company’s stock valued at $1,248,000 after purchasing an additional 39,592 shares during the period. Quarry LP bought a new position in Afya in the 3rd quarter valued at $75,000. Point72 Asset Management L.P. bought a new position in Afya in the 3rd quarter valued at $842,000. Finally, Centiva Capital LP bought a new position in Afya in the 3rd quarter valued at $213,000. 88.02% of the stock is owned by institutional investors.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.